Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Galaxy S26 Ultra Could Be 6% More Expensive Than Galaxy S25 Ultra Due To DRAM, NAND Price Increases; Samsung Betting On AI, SoC Upgrade & New Camera To Generate Sales